The administration of SBCT and VMT could inhibit NF-κB activation, iNOS, and COX-2 expression, and confirmed the involvement of the innate immune system in the anti-BV mechanism of the microecological environment. This evidence concerns the gene NFKB1 and bacterial vaginosis.